Capital International Investors Grows Stock Holdings in Albemarle Co. (NYSE:ALB)

Capital International Investors lifted its position in shares of Albemarle Co. (NYSE:ALBFree Report) by 31.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,800,219 shares of the specialty chemicals company’s stock after purchasing an additional 1,396,624 shares during the period. Capital International Investors’ holdings in Albemarle were worth $838,025,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. USCF Advisers LLC lifted its position in shares of Albemarle by 100.0% during the 4th quarter. USCF Advisers LLC now owns 200 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 100 shares during the last quarter. Arlington Trust Co LLC acquired a new stake in Albemarle during the 4th quarter worth $30,000. Jones Financial Companies Lllp raised its stake in Albemarle by 2,942.9% during the 4th quarter. Jones Financial Companies Lllp now owns 213 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 206 shares in the last quarter. Tyler Stone Wealth Management acquired a new stake in Albemarle during the 3rd quarter worth $35,000. Finally, VisionPoint Advisory Group LLC raised its stake in Albemarle by 21,400.0% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 215 shares of the specialty chemicals company’s stock worth $37,000 after acquiring an additional 214 shares in the last quarter. 92.87% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO John Clarence Barichivich III sold 1,475 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $132.17, for a total transaction of $194,950.75. Following the sale, the chief accounting officer now owns 4,743 shares of the company’s stock, valued at $626,882.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, SVP Mark Richard Mummert sold 843 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $135.53, for a total transaction of $114,251.79. Following the sale, the senior vice president now owns 6,802 shares of the company’s stock, valued at $921,875.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO John Clarence Barichivich III sold 1,475 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $132.17, for a total transaction of $194,950.75. Following the completion of the sale, the chief accounting officer now directly owns 4,743 shares in the company, valued at approximately $626,882.31. The disclosure for this sale can be found here. 0.38% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ALB shares. Vertical Research lowered shares of Albemarle from a “buy” rating to a “hold” rating and set a $145.00 price target on the stock. in a research note on Friday, March 8th. Scotiabank reiterated a “sector perform” rating and set a $135.00 price target (down from $150.00) on shares of Albemarle in a research note on Tuesday, May 21st. Mizuho lifted their price target on shares of Albemarle from $112.00 to $128.00 and gave the stock a “neutral” rating in a research note on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Albemarle from $125.00 to $140.00 and gave the stock a “hold” rating in a research note on Tuesday, May 7th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $157.00 price target on shares of Albemarle in a research note on Friday, May 24th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $165.16.

Get Our Latest Report on ALB

Albemarle Stock Performance

Shares of Albemarle stock traded up $1.06 on Wednesday, reaching $119.37. 960,248 shares of the stock were exchanged, compared to its average volume of 2,993,991. Albemarle Co. has a 1-year low of $106.69 and a 1-year high of $247.44. The company has a current ratio of 2.84, a quick ratio of 1.91 and a debt-to-equity ratio of 0.37. The business has a fifty day moving average price of $124.74 and a two-hundred day moving average price of $126.09. The firm has a market capitalization of $14.03 billion, a PE ratio of 43.03, a PEG ratio of 3.03 and a beta of 1.61.

Albemarle (NYSE:ALBGet Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.09). Albemarle had a return on equity of 14.53% and a net margin of 4.02%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm earned $10.32 earnings per share. The company’s revenue was down 47.3% compared to the same quarter last year. As a group, research analysts anticipate that Albemarle Co. will post 2.49 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Friday, June 14th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend is Friday, June 14th. Albemarle’s dividend payout ratio is currently 58.18%.

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Articles

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.